Abstract:Objective: To explore the effects of amiodarone on proliferation and cell cycle distribution of human hepatocellular cancer (HCC) cell HepG2 in vitro, and to discuss the possible molecular mechanism. Methods: The absorbance value and cell inhibition rate of proliferation of HepG2 cells were detected by MTT test, and parameters of cell cycle distribution was measured by flow cytometry using propidium iodide (PI) staining after being treated by amiodarone or 5-fluorouracil (5-Fu); and, accordingly, the characteristics of amiodarone on proliferation and cell cycle distribution of HepG2 were analyzed. Results: HepG2 cells shrank and refractive index decreased gradually along with the increase of concentration of amiodarone from 0.5 μg/ml to 4 μg/ml, while there were gradual growth in quantity observed of dead cells. The proliferation of HepG2 cells was inhibited dramatically, which showed obvious concentration-effect relation and time-effect relation. There were marked differences in parameters of cell cycle distribution and inhibition rates between amiodarone group and control group, which were of statistical significance (P<0.01); however, no statistical significance was observed between amiodarone group and 5-Fu group(P>0.05). The characteristics of cell cycle distribution changed markedly when HepG2 cells were interfered with amiodarone at 0.5-4.5 mg/L in vitro: the percentage of cells in stage G0/G1 and G 2/M increased, while that of cells in stage S reduced. The trend was similar to that of 5-Fu group. Conclusion: Amiodarone can inhibit the proliferation of HepG2 in vitro, which showed concentration-effect relation and time-effect relation. Amiodarone might be a new alternative of neoadjuvant chemotherapy for patients with HCC.

The Effects of Furazolidoze on Cell Proliferation and Cell Cycle of Hep G2

Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells.

Opposite effects of JNK and p38 MAPK signaling pathways on furazolidone-stimulated S phase cell cycle arrest of human hepatoblastoma cell line.

The Effect of GADD45a on Furazolidone‐Induced S‐Phase Cell‐Cycle Arrest in Human Hepatoma G2 Cells

Establishment of a 5-DFUR-resistant human hepatocellular carcinoma cell model and preliminary study of the mechanisms of the drug resistance]

Furazolidone Induced Oxidative DNA Damage Via Up-Regulating ROS That Caused Cell Cycle Arrest in Human Hepatoma G2 Cells

Involvement of the Activation of Nrf2/HO-1, P38 MAPK Signaling Pathways and Endoplasmic Reticulum Stress in Furazolidone Induced Cytotoxicity and S Phase Arrest in Human Hepatocyte L02 Cells: Modulation of Curcumin.

P21(Waf1/Cip1) Plays a Critical Role in Furazolidone-Induced Apoptosis in HepG2 Cells Through Influencing the Caspase-3 Activation and ROS Generation.

Effects of Chlorzoxazone on HepG2 Tumor Cells

Effect of Fumonisin B-1 on the Cell Cycle of Normal Human Liver Cells

Furanodiene Induces G(2)/M Cell Cycle Arrest And Apoptosis Through Mapk Signaling And Mitochondria-Caspase Pathway In Human Hepatocellular Carcinoma Cells

Curcumin Ameliorates Furazolidone-Induced DNA Damage and Apoptosis in Human Hepatocyte L02 Cells by Inhibiting ROS Production and Mitochondrial Pathway.

Effects of quercetin on proliferation and Cyclin D2 gene expression of HepG2 cells

Effect of Hepatic Targeting Drug Gal-HSA-5-FU on Proliferation and Cell Cycle of Human Hepatocarcinoma Cells (Bel-7402)

Effects and Significance of Amiodarone on the Proliferation of Human Hepatocellular Carcinoma Cell Line HepG2 in Vitro

The Effects of ~(18)F-FDG on the Proliferation of HepG2 Liver Cancer Cells

Tumor Inhibiting and Immunoloregulation Effects of "Fuzheng Huoxue Kangai Prescription" on H22 Cancer-Bearing Mice

Experimental Study on the Effect of Resveratrol on Cell Cycle of HepG2 Cells

Effects of chloroquine on proliferation and cell cycle of hepatocellular carcinoma cell line HepG2 cultured in vitro

Furazolidone induces apoptosis through activating reactive oxygen species-dependent mitochondrial signaling pathway and suppressing PI3K/Akt signaling pathway in HepG2 cells.

Exfoliazone Inhibits the Growth of HepG2 Cells by Inducing Apoptosis